Screening mammography is performed in asymptomatic women without a personal history of breast cancer. The aim of screening is to reduce mortality from breast cancer. Screen-detected cancers are likely to be small and node negative and better differentiated when compared to symptomatic cancers. Screening must be backed up by accurate diagnostic assessment, image-guided biopsies, breast pathology, and treatment.
KeywordsBreast Cancer Dense Breast Mammographic Screening Sojourn Time Digital Mammography
- 1.Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, Böhm-Vélez M, Mahoney MC, Evans 3rd WP, Larsen LH, Morton MJ, Mendelson EB, Farria DM, Cormack JB, Marques HS, Adams A, Yeh NM, Gabrielli G, ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.PubMedCentralPubMedCrossRefGoogle Scholar
- 4.Miller AB, Wall C, data manager, Baines CJ, Sun P, statistician Teresa To, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial. BMJ. 2014;348;g366.Google Scholar
- 6.Screening for Breast Cancer- USPSTF Recommendations. http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.html.
- 7.Shapiro S. Screening for breast cancer: the HIP Randomized Controlled Trial. Health Insur Plan. J Natl Cancer Inst Monogr. 1997;(22):27–30.Google Scholar